Who is sponsoring NCT04808336?

NCT04808336 is sponsored by Menoufia University.

What drugs are being tested in NCT04808336?

Interventions in NCT04808336: PRP injection., fixation surgical procedure.

What condition does NCT04808336 study?

NCT04808336 studies Degenerative Spondylolisthesis G1.

Is NCT04808336 still recruiting?

NCT04808336 is currently completed. Last updated 22 March 2021.

Last reviewed 2021-03-22 · How we verify

NCT04808336

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Platelet Rich Plasma Injection Versus Surgical Fixation Procedure in Management of Spondylolisthesis grade1.

Completed NA Last updated 22 March 2021

What this trial tests

NA trial testing PRP injection. in Degenerative Spondylolisthesis G1 in 60 participants. Completed in 26 May 2020.

Timeline

26 March 2019

Primary endpoint
2 May 2020

26 May 2020

Quick facts

Lead sponsor	Menoufia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	26 March 2019
Primary completion	2 May 2020
Estimated completion	26 May 2020
Sites	1 location across Egypt

Drugs / interventions tested

PRP injection.
fixation surgical procedure

Conditions studied

Degenerative Spondylolisthesis G1 — all drugs for Degenerative Spondylolisthesis G1 →

Sponsor

Menoufia University

Who can join

Adults 18 to 50, any sex, with Degenerative Spondylolisthesis G1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Spondylolisthesis is a serious health condition that is often treated with surgery or pain-relieving lumbar epidural steroids. Patients with persistent and debilitating symptoms who have failed to respond to conservative treatment should consider surgery. Objectives: The aim of this study was to compare the therapeutic efficacy of three ultrasound guided PRP injections of the facet joint capsule to surgical procedures in patients with degenerative spondylolisthesis G1 and their effect on neurogenic pain relief and functional improvement over a one-year follow-up period. Methods: A one-year prospective randomised comparative clinical trial was performed on 60 patients with degenerative spondylolisthesis G1 who were randomly assigned to one of two groups: Group 1: thirty patients were injected in the facet joint capsule with a series of three ultrasound-guided PRP injections at four-week intervals, and Group 2: thirty patients underwent surgery. They were exposed to clinical neuropsychological testing.They were assessed for pain and function using clinical neurological assessments, VAS (Visual Analogue Scale), FRI (Functional Rating Index), Roland Morris, and ODI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Degenerative Spondylolisthesis G1

Currently open trials in the same condition.

NCT07303348 — Multicenter Clinical Randomized Controlled Trial of Unilateral Biportal Endoscopic Spinal Surgery for Degenerative Grade · NA · active not recruiting

Other Menoufia University trials

Trials by the same sponsor.

NCT07522671 — Clinical Performance of 3D-Printed Resin and Zirconia Implant Restorations · NA · recruiting
NCT07516236 — Dynamic SvO2 in Predicting Fluid Responsiveness in Septic Shock · not yet recruiting
NCT07485517 — Deep Versus Moderate Neuromuscular Blocking · NA · recruiting
NCT07506044 — Dexmedetomidine as an Adjuvant During Dural Puncture Epidural · NA · recruiting
NCT07322471 — Efficacy and Safety of Flexible Ureteroscopy Versus Percutaneous Nephrolithotomy in Management of Staghorn Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04808336 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Menoufia University
Last refreshed: 22 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04808336.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing